LARVOL CLIN vs HemOncBytes
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
LARVOL CLIN
This app provides oncologists, researchers, and pharma professionals with quick access to clinical trials, cancer research, and oncology data. It integrates trial analytics, research insights, and drug pipeline intelligence for informed decision-making in cancer research and drug development.
- Clinical trial analytics
- Oncology research insights
- Drug pipeline intelligence
- Data-driven decision making
- Comprehensive oncology data
Read full descriptionHide full description
CLIN is a comprehensive oncology intelligence app designed for oncologists, clinical researchers, and pharma professionals who need fast, reliable access to clinical trials, cancer research, and oncology data. The app brings together clinical trial analytics, oncology research insights, and drug pipeline intelligence in a single, easy-to-use mobile experience—helping users stay informed and make data-driven decisions in cancer research and drug development.
HemOncBytes
Stay current with hematology and oncology information through concise, actionable updates. This app uses a microlearning and active recall method to boost clinical confidence and decision-making speed. Content is clinically relevant and vetted by practicing oncologists.
- Quick, actionable bytes of information
- Microlearning and active recall
- Clinically relevant content
- Vetted by practicing oncologists
- Boosts clinical confidence
- Practice-changing updates
Read full descriptionHide full description
Are you drowning in oncology information overload? There's a better way to stay current in oncology. HemOncBytes delivers core heme/onc knowledge + practice-changing updates in quick, actionable bytes. * Reclaim hours weekly * Boost clinical confidence * Make informed decisions, faster Learn smarter, not harder. Our unique Bytes Method combines microlearning with active recall, ensuring you not only learn faster but retain more. Created and vetted by practicing oncologists, every piece of content is clinically relevant, immediately applicable, and designed to help you make confident decisions at the point of care.
Screenshots
Verdict
The clearest difference is in-app purchases: LARVOL CLIN at none against HemOncBytes's 1. HemOncBytes's advantage is ratings volume (7 vs 1). On price, rating, update cadence and ads there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. HemOncBytes sells 1 one-off in-app purchase. LARVOL CLIN asks for nothing beyond the download.
On the App Store both sit at effectively the same score — 5.0 for LARVOL CLIN against 5.0 for HemOncBytes. That said, the two scores are not equally well evidenced: HemOncBytes has 7 ratings behind it against 1, so its average is the more settled of the two.
Both ship on a similar rhythm, roughly every 2 months. The most recent releases landed on July 17, 2026 and July 18, 2026 respectively.
| Parameter | LARVOL CLIN | HemOncBytes |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (1 ratings) | 5.0 (7 ratings) |
| Positive reviews | — | 100.0% of reviews |
| Number of ratings | 1 | 7 — better |
| Update frequency | Every 2 months | Every 2 months |
| Ads | No | No |
| In-app purchases | No — better | Yes |
| Monetization | Free — better | Free with in-app purchases |
| Devices | iPhone, iPod | iPhone, iPad, iPod — better |
| Requires iOS | 15.1 — better | 15.2 |
| Further details — not scored | ||
| Size | 31 MB | 112 MB |
| Age rating | 4+ | 4+ |
| Developer | THE LARVOL GROUP, LLC | VitalFolio LLC |
Customer experience
LARVOL CLIN
HemOncBytes
In-app purchases
LARVOL CLIN
No in-app purchases
HemOncBytes
- Best of ASCO 2025$100.00
